Pulmonary Cell News Volume 9.38 | Oct 1 2020

    0
    27







    2020-01-10 | PULCN 9.38


    Pulmonary Cell News by STEMCELL Technologies
    Vol. 9.38 – 1 October, 2020
    TOP STORY

    STAT3–BDNF–TrkB Signaling Promotes Alveolar Epithelial Regeneration after Lung Injury

    Single-cell transcriptome analysis identified brain-derived neurotrophic factor as a STAT3 target gene with newly accessible chromatin in a unique population of regenerating AT2 cells.
    [Nature Cell Biology]

    Full Article


    Virtual Conference Exhibition: Organoids
    PUBLICATIONSRanked by the impact factor of the journal

    Proteome-Wide
    Effects of Naphthalene-Derived Secondary Organic Aerosol in BEAS-2B Cells Are Caused by Short-Lived Unsaturated Carbonyls

    The authors investigated the dynamic toxicities of naphthalene-derived secondary organic aerosol in a human bronchial epithelial cell line and identified the chemical components responsible for toxicities.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Abstract

    miR-184
    Targets TP63 to Block Idiopathic Pulmonary Fibrosis by Inhibiting Proliferation and Epithelial–Mesenchymal Transition of Airway Epithelial Cells

    Investigators showed abnormal upregulation of tumor protein p63 (TP63) and downregulation of miR-184 in idiopathic pulmonary fibrosis. Transforming growth factor beta 1 stimulation of BEAS-2B and A549 cell lines significantly increased the protein levels of Tp63, alpha-smooth muscle actin, and vimentin, but decreased EpCAM protein levels, and promoted viability of both BEAS-2B and A549 cell lines.
    [Laboratory Investigation]

    Full Article

    PM014
    Attenuates Radiation-Induced Pulmonary Fibrosis via Regulating NF-kB and TGF-b1/NOX4 Pathways

    Scientists investigated the radioprotective effects and the underlying mechanism of the standardized herbal extract PM014 on radiation-induced lung fibrosis.
    [Scientific Reports]

    Full Article

    Heterogeneous
    Ozone Effects on the DNA Methylome of Bronchial Cells Observed in a Crossover Study

    Researchers used a randomized crossover experiment to estimate the effects of ozone exposure on genome-wide DNA methylation of target bronchial epithelial cells, using 17 volunteers, each randomly exposed on two separated occasions to clean air or 0.3-ppm ozone for two hours.
    [Scientific Reports]

    Full Article

    Hydrogen
    Peroxide Causes Cell Death via Increased Transcription of HOXB13 in Human Lung Epithelial A549 Cells

    Scientists studied the role of homeobox protein B13 (HOXB13) in cytotoxicity caused by hydrogen peroxide in human lung epithelial A549 cells. The knockdown of HOXB13 reduced hydrogen peroxide-induced cytotoxicity; however, this phenomenon was largely absent in the presence of antioxidants.
    [Toxics]

    Full Article

    LUNG CANCER

    Multilineage
    Murine Stem Cells Generate Complex Organoids to Model Distal Lung Development and Disease

    The authors established a three‐dimensional murine bronchioalveolar lung organoid model that allowed clonal expansion and self‐organization of FACS‐sorted bronchioalveolar stem cells upon co‐culture with lung‐resident mesenchymal cells.
    [EMBO Journal]

    AbstractGraphical Abstract

    FGFR1
    Is Critical for Rbl2 Loss-Driven Tumor Development and Requires PLCG1 Activation for Continued Growth of Small Cell Lung Cancer

    Researchers showed that increased fibroblast growth factor receptor 1 (FGFR1) promoted tumorigenic progression in precancerous neuroendocrine cells and was required for small cell lung cancer development in vivo.
    [Cancer Research]

    Abstract

    MicroRNA-3613-5p
    Promotes Lung Adenocarcinoma Cell Proliferation through a RELA and AKT/MAPK Positive Feedback Loop

    Scientists determined that microRNA-3613-5p plays a crucial role in RELA-mediated post-transcriptional regulation of lung adenocarcinoma cell proliferation.
    [Molecular Therapy-Nucleic Acids]

    AbstractGraphical Abstract

    Bone
    Marrow Mesenchymal Stem Cells-Derived Exosomal MicroRNA-193a Reduces Cisplatin Resistance of Non-Small Cell Lung Cancer Cells via Targeting LRRC1

    A549 and H1299 cell lines were screened out and their parent cells and drug-resistant cells were co-cultured with human bone marrow mesenchymal stem cells-derived exosomes that had been transfected with miR-193a mimic or si-LRRC1 to detect the colony formation, migration, apoptosis, invasion and proliferation of non-small cell lung cancer cells.
    [Cell Death & Disease]

    Full Article

    MicroRNA-130b
    Functions as an Oncogene and Is a Predictive Marker of Poor Prognosis in Lung Adenocarcinoma

    Researchers investigated the clinicopathologic significance of microRNA-130b in lung adenocarcinoma and analyzed its cancer-specific functions.
    [Laboratory Investigation]

    Abstract


    Grow Functional Airway Organoids with PneumaCult™
    REVIEWS

    Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)

    EGFR mutations are the most common oncogenic drivers in NSCLC. Significant developments have taken place which highlight the differences in tumor biology that exist between the mutant and wild-type subtypes of NSCLC.
    [Pharmaceuticals]

    Full Article

    INDUSTRY AND POLICY NEWS

    Windtree Announces FDA Acceptance of IND Application for a Phase II Clinical Trial Studying KL4 Surfactant in Acute Lung Injury in Adults with COVID-19

    Windtree Therapeutics, Inc. announced that FDA has accepted its Investigational New Drug application for a Phase II clinical trial studying lyo lucinactant, its KL4 surfactant drug, in COVID-19 associated lung injury and acute respiratory distress syndrome patients.
    [Windtree Therapeutics, Inc.]

    Press Release

    FDA
    Approves KALYDECO® (Ivacaftor) as First and Only CFTR Modulator to Treat Eligible Infants with CF as Early as Four Months of Age

    Vertex Pharmaceuticals Incorporated announced the FDA approved KALYDECO® for use in children with cystic fibrosis ages four months to less than six months old who have at least one mutation in their cystic fibrosis transmembrane conductance regulator gene that is responsive to KALYDECO based on clinical and/or in vitro assay data.
    [Vertex Pharmaceuticals Incorporated]

    Press Release

    FEATURED EVENT

    Stem Cells and Cancer

    May 16 – May 21, 2021
    Lucca, Italy


    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellow – Pharmacogenomics and Integrative Genomics

    University of California, San Diego – La Jolla, California, United States

    Postdoctoral
    Research Associate – Acute Lung Injury

    Old Dominion University – Norfolk, Virginia, United States

    Postdoctoral
    Positions – Signal Transduction

    NYU Langone Health – New York, New York, United States

    Postdoctoral Position – Lung Regeneration and Pollution

    Institut Mondor de Recherche Biomédicale (IMRB) – Creteil, France

    Margaret
    Turner Warwick Chair of Thoracic Medicine – Fibrosing Lung Disease

    National Heart and Lung Institute – London, United Kingdom

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Science News Pulmonary Cell News
    Archives Contact Us
    Pulmonary Cell News Twitter